glp-1 layoffs news medications could cut US mortality by 6.4%, new study finds Alarming rise in weight loss

The only head-to-head trial (SURPASS-2) compared tirzepatide to semaglutide 1 mg for diabetes and found tirzepatide better for both HbA1c and weight

Scientists are experimenting with new ways to make skin delivery possible, but for now, the only methods that actually work are injections and Rybelsus

A recent meta-analysis of Phase 3 trials reported increases in HR, based on single time point assessments, in the range of 14 bpm with both long- and short-acting GLP-1 RAs [15]

The Therapeutic Goods Administration (TGA) in Australia has been working with Novo Nordisk, pharmaceutical wholesalers and organisations representing health professionals and patient groups to manage the current shortage

Plus, a long-term study found that swapping one daily serving of animal protein for plant protein (like peanuts or peanut butter) decreases your risk of developing type 2 diabetes

Understanding return policies, replacement procedures, and dispute resolution before purchasing sets appropriate expectations